Consumer staples exchange-traded funds (ETFs) are a common way for investors to add defensive ballast to a portfolio, but not all staples funds are built alike. FXG and RSPS both sit in the same broad sector, yet their indexing approaches produce meaningfully different exposure profiles, cost structures, and risk characteristics. Comparing them is a useful exercise in understanding how weighting methodology — rather than just sector selection — drives relative positioning and fund performance. For investors weighing these two funds, the key question is whether a factor-tilted, slightly more concentrated approach or a straightforward equal-weight approach better suits their goals in the current market environment.
FXG seeks to track the StrataQuant Consumer Staples Index, a modified equal-dollar-weighted benchmark built using the AlphaDEX screening methodology. Rather than simply capitalizing the sector by market value, the index screens constituents of the Russell 1000 using multiple fundamental factors — including value and growth metrics — to identify stocks that may generate excess returns relative to traditional passive indexes. The fund typically holds around 41 securities, and its top 10 positions represent roughly 40% of net assets, giving it a moderately concentrated profile. Recent top holdings have included Bunge Global (BG), McKesson (MCK), Smithfield Foods (SFD), Pilgrim's Pride (PPC), and Ingredion (INGR). Notably, its factor-driven selection pulls in non-staples names such as healthcare distributors, so the portfolio is not a pure staples sleeve. FXG carries a 0.63% expense ratio and is passively managed but actively screened. I also checked this using Tickeron’s AI Screener to see how the stock selection compares to peers in the space.
RSPS seeks to replicate the S&P 500 Equal Weight Consumer Staples Index, which equally weights the consumer staples constituents of the S&P 500 as classified under the Global Industry Classification Standard (GICS, the widely used framework for categorizing companies by sector and industry). The fund holds roughly 37–39 names, each representing close to 3% of assets, and rebalances quarterly to restore equal weighting. This structure prevents any single mega-cap from dominating returns and gives smaller constituents a proportionate voice. Recent top holdings have included Kroger (KR), Philip Morris International (PM), Procter & Gamble (PG), Costco Wholesale (COST), and Walmart (WMT). The portfolio is almost entirely consumer defensive, with only a small consumer cyclical sleeve, and it carries a 0.40% expense ratio.
Consumer staples occupy a defensive niche in equity markets because demand for food, beverages, household goods, and tobacco remains relatively stable across economic cycles. In recent market cycles, elevated inflation, shifting interest-rate expectations, and trade-policy uncertainty have supported demand for defensive sectors with lower beta and steadier cash flows. At the same time, staples companies face margin pressure from input-cost inflation and mixed consumer spending as households trade down or seek value. Structural themes also matter. The rise of weight-loss drugs (often called GLP-1 medications) has pressured packaged-food and snack volumes, while beverage and household-products franchises have proven more resilient. Equal-weight funds such as RSPS capture this breadth evenly, whereas factor-tilted funds like FXG may concentrate in specific sub-industries such as food producers and healthcare distribution, amplifying sub-sector-specific risks and rewards.
Over recent weeks and months, both funds have behaved as relatively low-volatility defensive vehicles, though their relative positioning has diverged. RSPS has benefited from a more balanced footprint across household-products, beverage, and retail names, which has helped it participate when staples leadership broadened. FXG, by contrast, has been more exposed to food-related and agricultural commodity-linked names, which can amplify sensitivity to commodity trends and consumer taste shifts. Cost is a persistent drag on FXG: its 0.63% expense ratio is notably higher than RSPS's 0.40%, a gap that compounds over time in a sector where total returns are often modest and income-focused. In terms of volatility, both funds show low betas relative to the broad market, but FXG's heavier top-10 concentration introduces greater single-name risk than RSPS's equal-weight structure. For investors prioritizing relative positioning consistency and cost efficiency, RSPS's construction has been comparatively favorable in the current environment.
In my research process, I often turn to Tickeron’s AI Screener to filter ETFs and stocks by expense ratio, sector exposure, and volatility metrics. It surfaces comparable ideas quickly and helps confirm how different weighting methodologies stack up without manual number-crunching. This kind of tool has become a regular part of my workflow when evaluating defensive sector funds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 74 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples